To determine in vivo antitumor efficacy, we established disseminated AML and MM models via intravenous (i.v.)injection of MOLM-13 and MM.1s.CD1d in immunodeficient NOD scid gamma (NSG) mice. The gene discussed is CD1D; the disease is acute myeloid leukemia.